Warfarin

But researchers at the University of Cincinnati -- supported by the National Science Foundation -- are developing materials and technology for a simple in-home screening that could be a game changer for patients with several life-threatening conditions. Patients with cardiovascular disease, hyperten more

A major study is under way at The University of Nottingham which could lead to better prevention of a serious and sometimes fatal complication in cancer patients. Venous thromboembolism (VTE or ‘blood clotting’) is one of the most common causes of death in the UK and 20 per cent of these deaths are more

London Genetics Limited announced that it has augmented the strength of its team with the appointment of two senior advisers, Professors Stephen DeCherney and Munir Pirmohamed. Stephen DeCherney MD, MPH, is Professor of Medicine at the University of Carolina, and was previously President, Global Cl more

Abstract Introduction Ablation in the left ventricle (LV) is associated with a risk of thromboembolism. There are limited data on the use of specific thromboembolic prophylaxis strategies post‐ablation. We aimed to evaluate a thromboembolic prophylaxis protocol after ventricular tachycardia (V more

Milestone 2: Warfarin: from rat poison to clinical use Milestone 2: Warfarin: from rat poison to clinical use, Published online: 14 December 2017; doi:10.1038/nrcardio.2017.172 Milestone 2: Warfarin: from rat poison to clinical use more

Publication date: 15 November 2017 Source:European Journal of Pharmaceutical Sciences, Volume 109 Author(s): Ivana Lukášová, Jan Muselík, Aleš Franc, Roman Goněc, Filip Mika, David Vetchý Warfarin is intensively discussed drug with narrow therapeutic range. There have been cases of more